Myositis associated with localized lipodystrophy: an unrecognized condition?

Eur J Med Res. 2009 May 14;14(5):228-30. doi: 10.1186/2047-783x-14-5-228.

Abstract

Lipodystrophies represent a heterogeneous group of diseases characterized by altered body fat repartition and often metabolic alterations. Here we illustrate a 20 year old male with myositis in association with localized lipodystrophy. Immunohistochemical stainings revealed a regular pattern of dystrophin, dysferlin, sarcoglycans, and theletonin. Furtermore, there was no evidence of Lamin A/C deficiency. A nearly identical clinical and histological picture has been described in three patients up to now. Although it is difficult to speculate on a causative pathophysiological mechanism at this time, it is possible that this association represents an unrecognized condition.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • Buttocks
  • CD4-CD8 Ratio
  • Dysferlin
  • Dystrophin / metabolism
  • Humans
  • Lipodystrophy / complications*
  • Lipodystrophy / drug therapy
  • Lipodystrophy / pathology
  • Male
  • Membrane Proteins / metabolism
  • Muscle Proteins / metabolism
  • Muscle, Skeletal / metabolism
  • Myositis / drug therapy
  • Myositis / etiology*
  • Myositis / pathology
  • Prednisolone / therapeutic use
  • Sarcoglycans / metabolism
  • Treatment Failure

Substances

  • Biomarkers
  • DYSF protein, human
  • Dysferlin
  • Dystrophin
  • Membrane Proteins
  • Muscle Proteins
  • Sarcoglycans
  • Prednisolone